Шановні коритсувачі репозитарію! В період з 31.12.2025 по 07.01.2026 на сервері репозитарію будуть виконуватися технічні роботи. Не намагайтеся в цей період розміщувати або редагувати свої роботи. Дякуємо за розуміння. Dear repository users! From 12/31/2025 to 01/07/2026, technical work will be performed on the repository server. Please do not attempt to post or edit your work during this period. Thank you for your understanding.
 

The influence of zofenopril in combination with spironolactone on the morpho-functional state of the myocardium in patients after a myocardial infarction in the presence of obesity

Abstract

Acute myocardial infarction (AMI) remains the leading cause of death from cardiovascular disease in the world. One of the risk factors for developing coronary heart disease (CHD) associated with the risk of AMI is obesity. Aim – to study the effectiveness of treatment with ACE-inhibitors (zofenopril vise versa enalapril) in combination with spironolacton after a myocardial infarction in patients with low ejection fraction and obesity of the abdominal type on the parameters of the morphofunctionalstate of the myocardium.

Description

Keywords

Citation

The influence of zofenopril in combination with spironolactone on the morpho-functional state of the myocardium in patients after a myocardial infarction in the presence of obesity / S. Borzova-Kosse, L. Rozymuradova, K. Mamedov, S. Mohamad // ISIC-2018 : [International Scientific Interdisciplinary Conference for medical students and young scientists, Kharkiv, 23–25 May, 2018] : abstract book / KNMU. – Kharkiv, 2018. – P. 95–96.

Endorsement

Review

Supplemented By

Referenced By